Week in Review

EPA suspends BP from new federal contracts, SEC Chairman to step down, and more.

  • The SEC brought charges against CR Intrinsic Investors hedge fund over alleged involvement in a $276 million insider trading scheme.
  • The Federal Trade Commission (FTC) filed an amicus brief in an antitrust action against Warner Chilcott over alleged “product hopping,” where brand-name pharmaceutical companies make minor changes to a patented drug in an attempt to impede generic competitors.
  • Democratic senators sought a “refinery-by-refinery” investigation by the Department of Justice (DOJ) claiming that the 2012 gas price spikes in California resulted from illegal market manipulation.